Immunosuppressive Treatment for Solid Organ Transplant Recipients-MedicareAccess (Medicare patients only)

Status

Closed
Closed Funds

This fund is temporarily closed to new patients due to lack of sufficient funding. Please continue to visit our Disease Funds page often, as replenished funds reopen as quickly as possible. If you currently have a grant with HealthWell, your grant will remain active for the entire 12 month grant cycle or until you have exhausted your allocated grant amount, whichever comes first. You can continue to use your pharmacy card or submit requests for reimbursements during your designated grant cycle.

Fund Type

Copay
Premium (Medicare Part B only)

Maximum Award Level

$1,200

Pharmacy Card Fund

Yes

Minimum Copay
Reimbursement Amount

Minimum Copay Reimbursement Amount

We encourage you to please use your HealthWell pharmacy card for any applicable charges as possible.

None

Minimum Premium
Reimbursement Amount

Minimum Premium Reimbursement Amount

We encourage you to please submit monthly reimbursement claims (even if your premium is paid on a bi-weekly basis).

None

Household Income Limit

400% of the Federal Poverty Level
(adjusted for household size and high
cost of living areas)

Fund Alerts

Sign up for email or text/call alerts to receive instant notifications.

Treatments Covered

  • Arava
  • Astagraf Xl
  • Atgam
  • Azasan
  • Azathioprine
  • Basiliximab
  • Brequinar
  • Cellcept
  • Cyclosporine
  • Cyclosporine, Modified
  • Daclizumab
  • Envarsus Xr
  • Everolimus
  • Gengraf
  • Gusperimus
  • Hecoria
  • Imuran
  • Inolimomab
  • Millipred
  • Mycophenolate
  • Mycophenolate Mofetil
  • Mycophenolate Sodium
  • Mycophenolic Acid
  • Myfortic
  • Neoral
  • Nulojix
  • Orthoclone Okt3
  • Prednisolone
  • Prednisone
  • Prograf
  • Rapamune
  • Rayos
  • Sandimmune
  • Simulect
  • Tacrolimus
  • Thymoglobulin
  • Zenapax
  • Zortress

Fund Definition

Assistance for solid organ transplant recipients to obtain the prescription drugs or biologics used for immunosuppressive treatment.

Grant Utilization

HealthWell estimates that patients use an average of $650 during their 12-month grant period for this disease area.

Do I Qualify?

HealthWell bases eligibility on an individual’s medical, financial and insurance situation. To qualify for HealthWell’s assistance, applicants must meet the following eligibility requirements:

  • Please make sure that HealthWell currently has a fund for your diagnosis/indication and that your medication is covered under that fund by visiting our Disease Funds listing. If we do not have a fund that currently covers your diagnosis, please check back as we frequently open and reopen programs as funding becomes available. The Foundation is able to help patients receiving treatment for indications for which we currently have an open fund. We can only assist with medications that have been prescribed to treat the disease/covered diagnosis. You will be asked to provide the Foundation with the patient’s diagnosis, which must be verified by a physician, nurse practitioner, or physician assistant’s signature. The patient must receive treatment in the United States.

  • This is a Medicare Access Fund. In order to qualify for premium assistance through this fund, you must have Medicare Part B. The Foundation will refer patients without Medicare to other programs, such as manufacturer patient assistance programs.

  • HealthWell assists individuals with incomes up to 300-500% of the Federal Poverty Level. The Foundation also considers the number in a household and cost of living in a particular city or state. If you believe you qualify for assistance, you may begin the application process here.

  • If you are receiving treatment in the U.S. and have met the eligibility criteria as listed, you are ready to apply! Please note that you will be asked to provide a Social Security Number in order to create a grant. This information is gathered to eliminate duplicate applications and is kept secure and confidential.

About Immunosuppression

The body’s immune system recognizes the difference between its own cells and foreign matter. It just can’t tell the difference between harmful foreign cells and those that are helpful, such as the foreign tissues in a transplanted organ. Transplant recipients commonly experience organ rejection because of this. “Rejection” means that the body’s immune system attacks the donor organ’s cells, reacting to them as if they were harmful. Medications that curb the immune system (called immunosuppressants) are essential for transplant recipients, because they prevent and treat rejection. Source: University of Pittsburgh Medical Center

Additional Educational Resources

You may also visit our Resource List to view other copayment organizations that may provide assistance.